Manufacturer of Controlled Substances; Notice of Registration, 3160 [2011-940]
Download as PDF
<![CDATA[
3160
Federal Register / Vol. 76, No. 12 / Wednesday, January 19, 2011 / Notices
Web site: https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed consent decree may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$26.50 (25 cents per page reproduction
cost) payable to the U.S. Treasury or, if
by e-mail or fax, forward a check in that
amount to the Consent Decree Library at
the stated address.
Maureen M. Katz,
Assistant Chief, Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 2011–973 Filed 1–18–11; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSKH9S0YB1PROD with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated May 28, 2010 and
published in the Federal Register on
June 8, 2010, (75 FR 32504), Stepan
Company, Natural Products Department,
100 W. Hunter Avenue, Maywood, New
Jersey 07607, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Coca Leaves (9040), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
listed controlled substance for the
manufacture of a bulk controlled
substance for distribution to its
customer.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Stepan Company to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Stepan Company to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
VerDate Mar<15>2010
17:04 Jan 18, 2011
Jkt 223001
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: December 20, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Dated: December 20, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–942 Filed 1–18–11; 8:45 am]
[FR Doc. 2011–939 Filed 1–18–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
Drug Enforcement Administration
Importer of Controlled Substances
Notice of Registration
By Notice dated May 28, 2010, and
published in the Federal Register on
June 8, 2010 (75 FR 32505), Meda
Pharmaceuticals, Inc. 705 Eldorado
Street, Decatur, Illinois 62523, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as an importer of Nabilone
(7379), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance as a finished
drug product in dosage form only for
distribution to its customers. The
company does not import the listed
controlled substance in bulk active
pharmaceutical ingredient (API) form.
There are no domestic sources of
Nabilone in finished drug product form
available in the United States. The U.S.
Food and Drug Administration has
approved this product for medical use
in the United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a),
and determined that the registration of
Meda Pharmaceuticals Inc. to import the
basic classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Meda Pharmaceuticals
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
PO 00000
Frm 00086
Fmt 4703
Sfmt 9990
By Notice dated April 20, 2010 and
published in the Federal Register on
April 26, 2010, (75 FR 21661), Stepan
Company, Natural Products Department,
100 W. Hunter Avenue, Maywood, New
Jersey 07607, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances:
Drug
Cocaine (9041) .............................
Benzoylecgonine (9180) ...............
Schedule
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Stepan Company to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Stepan Company to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 20, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–940 Filed 1–18–11; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 76, Number 12 (Wednesday, January 19, 2011)]
[Notices]
[Page 3160]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-940]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 20, 2010 and published in the Federal
Register on April 26, 2010, (75 FR 21661), Stepan Company, Natural
Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Stepan Company to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Stepan Company to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: December 20, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-940 Filed 1-18-11; 8:45 am]
BILLING CODE 4410-09-P
